Home/Filings/4/0001142576-10-000027
4//SEC Filing

Poulos Kevin P 4

Accession 0001142576-10-000027

CIK 0001142576other

Filed

May 16, 8:00 PM ET

Accepted

May 17, 7:31 PM ET

Size

5.0 KB

Accession

0001142576-10-000027

Insider Transaction Report

Form 4
Period: 2010-05-17
Poulos Kevin P
Chief Commerical Officer
Transactions
  • Other

    Common stock

    2010-05-17$9.57/sh+1,068$10,2227,547 total
Footnotes (1)
  • [F1]Acquired under the Company's employee stock purchase plan on May 17, 2010.

Issuer

OPTIMER PHARMACEUTICALS INC

CIK 0001142576

Entity typeother

Related Parties

1
  • filerCIK 0001380840

Filing Metadata

Form type
4
Filed
May 16, 8:00 PM ET
Accepted
May 17, 7:31 PM ET
Size
5.0 KB